TY  - CONF

T1  - A cost utility analysis of peginterferon alfa-2a (40KD) versus peginterferon alfa-2b (12KD) for the treatment of chronic hepatitis C (CHC) in the UK

JO  - VALUE HEALTH

PY  - 2005/11/01

AU  - Latimer NR

AU  - Lewis GJ

ED  - 

VL  - 8

IS  - 6

SP  - A58

EP  - A58

Y2  - 2024/12/22

ER  -